Business
Genvor to Present at the Life Sciences Virtual Investor Forum December 11th
Genvor to Present at the Life Sciences Virtual Investor Forum December 11th.
About this update from Genvor Incorporated
[{"type":"text","content":"\r\n\r\n \r\n \r\n Genvor to Present at the Life Sciences Virtual Investor Forum December 11th\r\n \r\n \r\n\r\n\r\nGenvor to Present at the Life Sciences Virtual Investor Forum December 11th\r\nCompany invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com\r\n\r\n\r\n\r\n\r\n\r\nWOODLAND, Calif., Dec. 04, 2025 (GLOBE NEWSWIRE) -- Genvor, Inc. (OTCQB: GNVR), a pioneer in AI-accelerated peptide technology for sustainable agriculture, today announced that Chad Pawlak, Chief Executive Officer, will present live at Life Sciences Virtual Investor Forum hosted by VirtualInvestorConferences.com, on December 11th. DATE: December 11th TIME: 12:30 pm ETLINK: REGISTER HEREAvailable for 1x1 meetings following the presentation. Schedule 1x1 Meetings here This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event. It is recommended that online investors pre-register and run the online system check to expedite participation and receive event updates. Learn more about the event at www.virtualinvestorconferences.com. Recent Company Highlights \r\n Expanded to 5 issued U.S. patents with 2 pending applications and 4 additional applications in preparation, plus international filings in Canada, Mexico, and China, providing comprehensive IP protection through 2038 for proprietary peptide technologies including antimicrobial, nutrient-enhancing, and insecticidal applications\r\n Successfully restored active OTCQB trading on October 9, 2025, positioning the company to accelerate capital formation as it scales field trials and commercialization efforts across multiple continents\r\n Established new operational laboratory in Woodland, California to support R&D for foliar and peptide-based formulations, expanding scientific capabilities to deliver innovation in sustainable agriculture\r\n About GenvorGenvor (OTCQB: GNVR) is pioneering the future of sustainable agriculture through its proprietary AI-accelerated peptide design platform that transforms single discoveries into multi-crop protection and optimization opportunities across diverse agricultural ...